NEW YORK (GenomeWeb News) – Integromics today announced a partnership with two Spanish organizations to develop new data analysis methods for clinical genomic studies.

In support of the work, Spain's government has awarded the partners €2 million ($2.6 million) to develop algorithms and statistical tools for identifying alternative splicing events that are associated with disease biomarkers or identifying therapeutic targets using RNA sequencing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.